[go: up one dir, main page]

AU2075295A - Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists - Google Patents

Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists

Info

Publication number
AU2075295A
AU2075295A AU20752/95A AU2075295A AU2075295A AU 2075295 A AU2075295 A AU 2075295A AU 20752/95 A AU20752/95 A AU 20752/95A AU 2075295 A AU2075295 A AU 2075295A AU 2075295 A AU2075295 A AU 2075295A
Authority
AU
Australia
Prior art keywords
agonists
chloro
amino
methoxybenzoic
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20752/95A
Inventor
Tiziano Croci
Umberto Guzzi
Michel Langlois
Luciano Manara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9402927A external-priority patent/FR2717174B1/en
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of AU2075295A publication Critical patent/AU2075295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU20752/95A 1994-03-14 1995-03-14 Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists Abandoned AU2075295A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US262574 1988-10-25
FR9402927 1994-03-14
FR9402927A FR2717174B1 (en) 1994-03-14 1994-03-14 Use of piperidinoethyl esters of 4-amino-5-chloro-2-methoxybenzoic acid as 5-HT4 agonists.
US26257494A 1994-06-20 1994-06-20
PCT/FR1995/000298 WO1995025100A1 (en) 1994-03-14 1995-03-14 Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists

Publications (1)

Publication Number Publication Date
AU2075295A true AU2075295A (en) 1995-10-03

Family

ID=26231004

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20752/95A Abandoned AU2075295A (en) 1994-03-14 1995-03-14 Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists

Country Status (2)

Country Link
AU (1) AU2075295A (en)
WO (1) WO1995025100A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096761A (en) * 1996-02-15 2000-08-01 Janssen Pharmaceutica N.V. Esters of 3-hydroxy-piperidinemethanol derivatives
NZ330263A (en) * 1996-02-15 1999-06-29 Janssen Pharmaceutica Nv Esters of 3-hydroxy-piperidinemethanol derivatives to improve gastric emptying
FR2766484B1 (en) * 1997-07-25 1999-09-17 Logeais Labor Jacques NOVEL STIMULATING BENZAMIDE DERIVATIVES OF HIGH AND LOW GASTROINTESTINAL MOTORITY
FR2821356A1 (en) 2001-02-23 2002-08-30 Cerep NOVEL ARYLCARBAMATE AND ARYLUREES DERIVATIVES, PREPARATIONS AND USES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1233877B (en) * 1961-07-25 1967-02-09 Ile De France Process for the preparation of substituted N- (tert. Aminoalkyl) -benzamides
CA2116024A1 (en) * 1991-08-20 1993-03-04 Francis David King 5-ht4 receptor antagonists

Also Published As

Publication number Publication date
WO1995025100A1 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
AU6178894A (en) Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
AU6489396A (en) Methods of making viscoelastic compositions
AU4437797A (en) Hydrogels of absorbable polyoxaesters
AU1869895A (en) Method of tissue characterization by ultrasound
AU2438297A (en) Combinations of angiostatic compounds
AU2557397A (en) Removal of tissue
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
AU1136297A (en) Methods and compositions for diagnosis of hyperhomocysteinemia
AU7050994A (en) Human mutant tissue factor compositions useful as tissue factor antagonists
AU7478694A (en) 3-aryl or heteroaryl-7-heteroaralkylamido cephalosporin compounds, compositions and methods of use
AU2605995A (en) Dopamine d1 agonists for the treatment of dementia
AU1115095A (en) Treatment of cellulose
AU2762395A (en) Process for the preparation of azanoradamantane benzamides
AU671577B3 (en) Compositions and methods for the control of smoking
AU1466095A (en) Dermatologic composition
AU2670695A (en) Preparation of purines
AU5427398A (en) Cytoperfusion of tissue specimens
AU3560595A (en) Preparation of cisapride
AU6723294A (en) Use of simmondsine
AU5953090A (en) Novel use of 1-phenyl-2-aminoethanol derivatives as healing agents
AU4276496A (en) 3-Thioheteroaryl cephalosporin compounds, compositions and methods of use
AU2075295A (en) Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
AU2548192A (en) New use of acidic polysaccharide esters as anti-ulcer agents
AU6597396A (en) Novel 3-amido-triiodophenyl esters as x-ray contrast agents